Cargando…

Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature

Skeletal muscle sodium channelopathies are a group of neuromuscular disorders associated with mutations in the SCN4A gene. Because principal sodium channel isoforms expressed in the skeletal muscles and the heart are distinct one from the other, this condition usually spares cardiac functioning. Non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavalli, Michele, Fossati, Barbara, Vitale, Raffaele, Brigonzi, Elisa, Ricigliano, Vito A. G., Saraceno, Lorenzo, Cardani, Rosanna, Pappone, Carlo, Meola, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988887/ https://www.ncbi.nlm.nih.gov/pubmed/29899727 http://dx.doi.org/10.3389/fneur.2018.00385

Ejemplares similares

Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
por: Callus, Edward, et al.
Publicado: (2018)

Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies
por: Renna, Laura Valentina, et al.
Publicado: (2019)

Sporadic MM-1 Type Creutzfeldt-Jakob Disease With Hemiballic Presentation and No Cognitive Impairment Until Death: How New NCJDRSU Diagnostic Criteria May Allow Early Diagnosis
por: Saraceno, Lorenzo, et al.
Publicado: (2018)

MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review
por: Ricigliano, Vito A. G., et al.
Publicado: (2018)

Editorial: New Insights in Skeletal Muscle Channelopathies - A Rapidly Expanding Field
por: Maggi, Lorenzo, et al.
Publicado: (2020)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Epicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome
por: Gonzalez-Melchor, Laila, et al.
Publicado: (2015)

Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis
por: Pagliarani, Serena, et al.
Publicado: (2022)

Ventricular fibrillation in lone atrial fibrillation as clinical manifestation of latent Brugada syndrome: Usefulness of flecainide testing
por: Pappone, Carlo, et al.
Publicado: (2015)

Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
por: Renna, Laura Valentina, et al.
Publicado: (2017)

Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
por: Alì, Marco, et al.
Publicado: (2020)

Exercise Testing With Flecainide Demonstrates Provocable Brugada Syndrome
por: Safabakhsh, Sina, et al.
Publicado: (2021)

First Family of MATR3-Related Distal Myopathy From Italy: The Role of Muscle Biopsy in the Diagnosis and Characterization of a Still Poorly Understood Disease
por: Cavalli, Michele, et al.
Publicado: (2021)

SCN4A as modifier gene in patients with myotonic dystrophy type 2
por: Binda, Anna, et al.
Publicado: (2018)

Brugada Syndrome: More than a Monogenic Channelopathy
por: Liantonio, Antonella, et al.
Publicado: (2023)

Autoimmune Channelopathies at Neuromuscular Junction
por: Huang, Kun, et al.
Publicado: (2019)

Sodium channelopathy with an overlap of Brugada syndrome, paroxysmal atrial fibrillation, and progressive cardiac conduction system dysfunction
por: Bakhit, Yasir, et al.
Publicado: (2023)

Concealed Substrates in Brugada Syndrome: Isolated Channelopathy or Associated Cardiomyopathy?
por: Di Resta, Chiara, et al.
Publicado: (2022)

Wolff‐Parkinson‐White, Brugada phenocopy, and flecainide toxicity: All in one patient
por: Alhaj, Eyad K., et al.
Publicado: (2019)

Cardiac sodium channelopathies
por: Amin, Ahmad S., et al.
Publicado: (2009)

Compound Heterozygous SCN5A Mutations in Severe Sodium Channelopathy With Brugada Syndrome: A Case Report
por: Nijak, Aleksandra, et al.
Publicado: (2020)

Measuring quality of life impairment in skeletal muscle channelopathies
por: Sansone, V A, et al.
Publicado: (2012)

The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!
por: Monasky, Michelle M., et al.
Publicado: (2021)

Sodium channelopathies of skeletal muscle result from gain or loss of function
por: Jurkat-Rott, Karin, et al.
Publicado: (2010)

Brugada ECG Pattern Unmasked by IV Flecainide in an Individual with Idiopathic Fascicular Ventricular Tachycardia
por: Gavin, Andrew R, et al.
Publicado: (2013)

An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies
por: Morales, Fernando, et al.
Publicado: (2020)

Flecainide challenge test: Predictors of unmasking of type 1 Brugada ECG pattern among those with non-type 1 Brugada ECG pattern
por: Prasad, Srinivasa, et al.
Publicado: (2016)

Structural Heart Alterations in Brugada Syndrome: Is it Really a Channelopathy? A Systematic Review
por: Oliva, Antonio, et al.
Publicado: (2022)

Neurotransmitters and Sodium Channelopathies; Possible Link?
por: Hammer, Michael F., et al.
Publicado: (2017)

Editorial: Emerging perspectives in sodium channelopathies
por: Groome, J. R., et al.
Publicado: (2022)

Clinical Diversity of SCN4A-Mutation-Associated Skeletal Muscle Sodium Channelopathy
por: Lee, Sang-Chan, et al.
Publicado: (2009)

Phenotypic heterogeneity in skeletal muscle sodium channelopathies: A case report and literature review
por: Saleem, Rashid, et al.
Publicado: (2013)

SCN1A channelopathies: Navigating from genotype to neural circuit dysfunction
por: Bryson, Alexander, et al.
Publicado: (2023)

The omics of channelopathies and cardiomyopathies: what we know and how they are useful
por: Pappone, Carlo, et al.
Publicado: (2020)

Brugada Syndrome: Progress in Diagnosis and Management
por: Pappone, Carlo, et al.
Publicado: (2019)

Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge
por: Chauveau, Samuel, et al.
Publicado: (2017)

Provocative testing using low dose oral flecainide for diagnosis of Brugada syndrome: a report of two cases
por: Amir, Muzakkir, et al.
Publicado: (2022)

Autolytic attempt mimicking Brugada type 1 electrocardiogram pattern due to flecainide toxicity. A case report
por: López Guillén, José Luis, et al.
Publicado: (2023)

Sodium Channel Myotonia Due to Novel Mutations in Domain I of Na(v)1.4
por: Pagliarani, Serena, et al.
Publicado: (2020)

RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence
por: Malatesta, Manuela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ttc3t7c5ihmp813bk5n0nfdlv0